| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/19/2012 | US20120015894 Aqueous hair cleansing agent |
| 01/19/2012 | US20120015886 Method for preparing recombinant peptide from spider venom and method for relieving pain |
| 01/19/2012 | US20120015876 Conjugates of glp-1 agonists and uses thereof |
| 01/19/2012 | US20120015060 Compositions comprising a lipophilic extract of zingiber officinale and an extract of cynara scolymus, which are useful for the prevention and treatment of oesophageal reflux and irritable bowel syndrome |
| 01/19/2012 | US20120015040 Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof |
| 01/19/2012 | US20120014997 Aryl sulfonamides |
| 01/19/2012 | US20120014989 PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS |
| 01/19/2012 | US20120014986 Compositions and methods for reducing inflammation |
| 01/19/2012 | US20120014975 Modified single domain antigen binding molecules and uses thereof |
| 01/19/2012 | US20120014973 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation |
| 01/19/2012 | US20120014970 Therapeutic Compositions for Treatment of Corneal Disorders |
| 01/19/2012 | US20120014969 ErbB3 ANTIBODIES |
| 01/19/2012 | US20120014967 Il-1beta binding antibodies and fragments thereof |
| 01/19/2012 | US20120014963 Probiotics, secretory iga and infection |
| 01/19/2012 | US20120014962 Method of inhibiting fibrogenesis and treating fibrotic disease |
| 01/19/2012 | US20120014956 Methods and compositions for predicting responsiveness to treatment with tnf-alpha inhibitor |
| 01/19/2012 | US20120014954 Sparc binding scfvs |
| 01/19/2012 | US20120014953 Treating and evaluating inflammatory disorders |
| 01/19/2012 | US20120014952 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120014950 Antibodies That Specifically Bind to DR3 |
| 01/19/2012 | US20120014946 Prevention and treatment of pain using monoclonal antibodies and antibody fragments to lysophosphatidic acid |
| 01/19/2012 | US20120014944 Prevention and treatment of pain using antibodies to lysophosphatidic acid |
| 01/19/2012 | US20120014943 Optimized Anti-CD30 Antibodies |
| 01/19/2012 | US20120014934 Enhanced Natural Colors |
| 01/19/2012 | US20120014920 Annexin and its use to treat inflammatory disorders |
| 01/19/2012 | US20120014910 Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis |
| 01/19/2012 | US20120014904 Vascular delivery systems |
| 01/19/2012 | US20120014886 Soothing cosmetic or pharmaceutical composition comprising a peptide which activates hmg-coa reductase |
| 01/19/2012 | US20120014884 Menthol-derivative compounds and use thereof as oral and systemic active agents |
| 01/19/2012 | CA2804877A1 Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain |
| 01/19/2012 | CA2804191A1 Prevention and treatment of pain using monoclonal antibodies and antibody fragments to lysophosphatidic acid |
| 01/19/2012 | CA2802641A1 Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators |
| 01/19/2012 | CA2768199A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 01/18/2012 | EP2407476A1 Steroid compound |
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2407179A1 External preparation containing analgesic/anti-inflammatory agent |
| 01/18/2012 | EP2406272A1 N-hydroxy c29-amide derivatives of oleandrane |
| 01/18/2012 | EP2406266A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| 01/18/2012 | EP2406265A2 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators |
| 01/18/2012 | EP2406255A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases |
| 01/18/2012 | EP2406223A2 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 01/18/2012 | EP2406220A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 01/18/2012 | EP2405973A2 Thiazolopyrimidine modulators as immunosuppressive agents |
| 01/18/2012 | EP2327413A9 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
| 01/18/2012 | EP1808446B1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/18/2012 | EP1776119B1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 01/18/2012 | EP1506196B1 Pyrazolopyrimidines as sodium channel inhibitors |
| 01/18/2012 | EP1486213B1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis |
| 01/18/2012 | CN102325796A Anti-human [alpha]9 integrin antibody and use thereof |
| 01/18/2012 | CN102325771A Imidazo [1, 2 -a] pyridines as jnk modulators |
| 01/18/2012 | CN102325768A Compounds and methods for the treatment of pain and other diseases |
| 01/18/2012 | CN102325767A 7-phenoxychroman carboxylic acid derivatives |
| 01/18/2012 | CN102325537A Treatment of immunosuppression-related disorders |
| 01/18/2012 | CN102321626A Means for inhibiting the expression of protein kinase 3 |
| 01/18/2012 | CN102321514A Health-care wine |
| 01/18/2012 | CN102321239A Preparation method of water-soluble toluylene compound prodrugs |
| 01/18/2012 | CN102321165A Hainantoxin-XXI and application of hainantoxin-XXI in preparing analgesic and anti-inflammatory drugs and in preparing reagent for studying TRPV1 channel |
| 01/18/2012 | CN102321156A Novel thymopentin compound and composition powder injection thereof |
| 01/18/2012 | CN102321144A Method for extracting ursolic acid from red jujube |
| 01/18/2012 | CN102321094A New Gelsmium elegans Benth. alkaloid compound as well as preparation method and application thereof |
| 01/18/2012 | CN102321077A Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 01/18/2012 | CN102321030A Heterocyclic inhibitors of MEK and methods of use thereof |
| 01/18/2012 | CN102321025A Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors |
| 01/18/2012 | CN102321020A LXR receptor modulators |
| 01/18/2012 | CN102320956A Sodium ferulate composition freeze-dried powder injection and preparation method thereof |
| 01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 01/18/2012 | CN102319382A Chinese medicine for treating carcinomatous pains |
| 01/18/2012 | CN102319354A Heat clearing and detoxication oral liquid, and preparation method thereof |
| 01/18/2012 | CN102319343A External cream used for treating toothache caused by inflammations |
| 01/18/2012 | CN102319316A Rapid bone hyperplasia healing agent |
| 01/18/2012 | CN102319313A Moxibustion fumigation sachet |
| 01/18/2012 | CN102319308A Preparation method of heat-clearing cough-relieving oral liquid for children |
| 01/18/2012 | CN102319300A Method for extracting total saponins from beesia calthaefolia medicinal material |
| 01/18/2012 | CN102319294A Double-vanilla preparation and preparation method thereof |
| 01/18/2012 | CN102319281A Traditional Chinese medicine preparation for invigorating blood circulation and relieving pain and preparation method thereof |
| 01/18/2012 | CN102319277A Method for preparing fumaria capreolata L. total alkaloid extract |
| 01/18/2012 | CN102319272A Application of ginkgolic acid in preparation of external preparation for treating dermatopathy |
| 01/18/2012 | CN102319266A krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 01/18/2012 | CN102319242A Application of indazole bi-aryl urea compound serving as protein kinase inhibitor |
| 01/18/2012 | CN102319240A Application of deacetylmycoepoxydiene serving as Hsp90 inhibitor |
| 01/18/2012 | CN102319237A Application of quercetin in preparation of medicament for inhibiting NLRP3 inflammation body |
| 01/18/2012 | CN102319229A Preparation method of diclofenac sodium transdermal patch |
| 01/18/2012 | CN102319211A Preparation process and application of tryptanthrin injection emulsion |
| 01/18/2012 | CN102319205A Ibuprofen injection and preparation method thereof |
| 01/18/2012 | CN102319192A Enzyme bathing material for clearing toxins of human body and preparation method thereof |
| 01/18/2012 | CN101810644B Production method of ant essential oil and ant oil soft capsule |
| 01/18/2012 | CN101721495B Chinese herbal medicine wine for treating rheumatoid arthritis |
| 01/18/2012 | CN101606979B Method for extracting component with activities of microbiological resistance and anti-inflammatory from nelumbo nucifer (nulumbo lutea) fruit (lotus seed) |
| 01/18/2012 | CN101590208B Medicament composition for treating rheumatoid arthritis, and preparation method thereof |
| 01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
| 01/18/2012 | CN101406466B Cinnamic acid transdermal patch and preparation technique thereof |
| 01/18/2012 | CN101322755B Medicament composition, external-use paste and preparation thereof |
| 01/17/2012 | US8097620 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 01/17/2012 | US8097616 Process for preparation of high-purity meloxicam and meloxicam potassium salt |
| 01/17/2012 | US8097589 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 01/17/2012 | US8097585 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
| 01/17/2012 | US8097279 Chewable soft capsule |
| 01/17/2012 | US8096419 Compound |
| 01/17/2012 | CA2489269C Composition for treatment of inflammatory disorders |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |